{"id":"W4317934829","doi":"10.51731/cjht.2023.551","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Reimbursement; Medicine; Regimen; Adjuvant; Oncology; Breast cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Cancer; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169733,0.0002186092,0.000241617,0.0008098886,0.0002052073,0.0006623139,0.0003241146,0.0003156631,0.01069916],"category_scores_gemma":[0.0007666353,0.00006474984,0.0003032572,0.0005941234,0.0002311033,0.0003225364,0.000254794,0.0004318737,0.001506556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003283055,"about_ca_system_score_gemma":0.002877057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0374375,"about_ca_topic_score_gemma":0.1186639,"domain_scores_codex":[0.999653,0.00007187852,0.00002660112,0.00003601695,0.0001707291,0.00004175061],"domain_scores_gemma":[0.9997258,0.0000543276,0.00005138863,0.000008711993,0.0001270238,0.00003272668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003908764,0.00004423294,0.0009640093,0.002504479,0.00009532553,0.0001550966,0.00003710672,0.0003244801,0.003115607,0.005227866,0.08635024,0.9007906],"study_design_scores_gemma":[0.0001578532,0.0002411996,0.004162543,0.001324285,0.00009870542,0.0004064189,0.00003101787,0.0001548474,0.003952825,0.0004074312,0.9890512,0.00001172434],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01618333,0.747167,0.001547706,0.008441798,0.001534073,0.0003091224,0.003022186,0.0002154908,0.2215794],"genre_scores_gemma":[0.2051305,0.5653984,0.004420662,0.008187304,0.0006871496,0.0002160986,0.00476147,0.00005083552,0.2111476],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0374375,"threshold_uncertainty_score":0.07443917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028653130584693,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}